Coldstream Capital Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-686
Closed -$542 1838
2025
Q1
$542 Buy
+686
New +$542 ﹤0.01% 3328